Brenda Reynolds

Director/Board Member at

iQur Ltd.

Health Technology

Commercial Services

Process Industries

Profile

Brenda Elizabeth Reynolds is the founder of PowderMed Ltd. (founded in 2004), Convergence Pharmaceuticals Ltd. (founded in 2010), and Calchan Ltd. (founded in 2011).
She held the title of Chief Operating Officer at PowderMed Ltd. from 2004 to 2008.
Dr. Reynolds currently holds multiple non-executive director positions at iQur Ltd., D3tex Ltd., Adiga Life Sciences, Inc., BQR Consulting Ltd., and Pleco Therapeutics BV.
She is also the owner of Questrax Ltd. Dr. Reynolds received an undergraduate degree from the University of Surrey.

Brenda Reynolds active positions

Companies	Position	Start
iQur Ltd. iQur Ltd. BiotechnologyHealth Technology Develops vaccines	Director/Board Member	-
Questrax Ltd.	Corporate Officer/Principal	20/08/2010
D3tex Ltd.	Director/Board Member	-
BQR Consulting Ltd.	Director/Board Member	-
Pleco Therapeutics BV Pleco Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Provides therapies that change the balance in the treatment of cancer	Director/Board Member	-

All active positions of Brenda Reynolds

Former positions of Brenda Reynolds

Companies	Position	End
Adiga Life Sciences, Inc. Adiga Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops novel immunotherapeutic products in which small components (peptides of allergen proteins are identified and administered in a regimen	Director/Board Member	23/11/2024
PowderMed Ltd. PowderMed Ltd. Pharmaceuticals: MajorHealth Technology Develops immunotherapeutic products	Founder	24/10/2008
University of Birmingham Enterprise Ltd. University of Birmingham Enterprise Ltd. Investment ManagersFinance University of Birmingham Enterprise invests in companies located in the United Kingdom. The firm focuses on academic consulting services and technology service sectors. It participates financing for early stage capital transactions.	Private Equity Investor	-
Calchan Ltd. Calchan Ltd. BiotechnologyHealth Technology Operates as a biotechnology company, which develops novel oral state dependent calcium channel modulators for chronic pain	Chief Executive Officer	-
░░░ ░░░░░░░░░ ░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	-

See the detail of Brenda Reynolds's experience

Training of Brenda Reynolds

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Brenda Reynolds's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	21
Pfizer Inc. Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients	Health Technology
Powderject Pharmaceuticals Plc Powderject Pharmaceuticals Plc Medical SpecialtiesHealth Technology Develops pharmaceutical products	Health Technology
G.D. Searle & Co., Inc. G.D. Searle & Co., Inc. Chemicals: SpecialtyProcess Industries Makes diversified line of chemicals and agricultural products	Process Industries
Scotia Holdings Plc Scotia Holdings Plc Miscellaneous Commercial ServicesCommercial Services Researches and develops bio-pharmaceuticals	Commercial Services
PowderMed Ltd. PowderMed Ltd. Pharmaceuticals: MajorHealth Technology Develops immunotherapeutic products	Health Technology
University of Surrey University of Surrey Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Altimmune UK Ltd. Altimmune UK Ltd. BiotechnologyHealth Technology Develops vaccines for mutating viruses	Health Technology
DC Biosciences Ltd. DC Biosciences Ltd. BiotechnologyHealth Technology Provides bioreagents and life science services	Health Technology
iQur Ltd. iQur Ltd. BiotechnologyHealth Technology Develops vaccines	Health Technology
Crescendo Biologics Ltd. Crescendo Biologics Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in the development of new medicines based on antibody fragment technology	Commercial Services
University of Birmingham Enterprise Ltd. University of Birmingham Enterprise Ltd. Investment ManagersFinance University of Birmingham Enterprise invests in companies located in the United Kingdom. The firm focuses on academic consulting services and technology service sectors. It participates financing for early stage capital transactions.	Finance
Questrax Ltd.
The Institute of Directors (United Kingdom) The Institute of Directors (United Kingdom) Miscellaneous Commercial ServicesCommercial Services Operates as membership organisation that provides events, development courses, networking and expert advice	Commercial Services
Convergence Pharmaceuticals Ltd. Convergence Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops neuropathic pain products	Health Technology
Beecham Pharmaceuticals (UK)
Calchan Holdings Ltd. Calchan Holdings Ltd. Pharmaceuticals: MajorHealth Technology Develops novel oral state-dependent calcium channel (CaV 2.2) modulators for chronic pain	Health Technology
D3tex Ltd.
Adiga Life Sciences, Inc. Adiga Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops novel immunotherapeutic products in which small components (peptides of allergen proteins are identified and administered in a regimen	Health Technology
BQR Consulting Ltd.
Calchan Ltd. Calchan Ltd. BiotechnologyHealth Technology Operates as a biotechnology company, which develops novel oral state dependent calcium channel modulators for chronic pain	Health Technology
Pleco Therapeutics BV Pleco Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Provides therapies that change the balance in the treatment of cancer	Commercial Services